glp 1 weight loss rate GLP-1 Agonists Drugs Market Report, 2025-2030 Study finds 40% of GLP-1
Description
Acknowledgements Thanks to the US FDA for providing a free source of data for the study
About one in eight Americans has taken a glucagon-like peptide-1 (GLP-1) agonist medication, such as Ozempic or Wegovy, according to the Kaiser Family Foundation
[DOI] [PMC free article] [PubMed] [Google Scholar] 63.Piening A, Ebert E, Gottlieb C, Khojandi N, Kuehm LM, Hoft SG, Pyles KD, McCommis KS, DiPaolo RJ, Ferris ST, Alspach E, Teague RM
It is available under the brand names Mounjaro (type 2 diabetes) and Zepbound (weight loss)
Gastaldelli A, Abdul Ghani M, DeFronzo RA
